Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia
NCT01373515
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia (AML)
Leukemic Dendritic Cell Vaccination
Interventions
BIOLOGICAL:
DCP-001
Sponsor
Mendus